Get the app
US › Healthcare

60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP)

US · Healthcare · Biotechnology

$0.85-4.89%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$207,898
Revenue YoY
+106.0%
Net profit
$-2.3M
EPS
$-0.90
EPS estimate
$-0.74
Net margin
-1,089.2%

EPS came in at -0.90 against a street estimate of -0.74 — a miss of 21.6%.

Key statistics

Market cap
$3.2M
Forward P/E
0.0
P/B
0.00
Book value
$-2.62
EPS (TTM)
$-5.34
52-week high
$6.36
52-week low
$0.84
50-day MA
$1.09
200-day MA
$1.86
Beta
2.40

Analyst view

Analysts rate 60 Degrees Pharmaceuticals, Inc. Common Stock a buy (1 buy, 1 hold, 0 sell out of 2) with an average price target of $3.70.

Shareholding

Insiders
19.39%
Institutions
17.11%

Largest institutional holders

FundStake
Kathmere Capital Management, LLC7.54%
Citadel Advisors Llc0.64%
XTX Topco Ltd0.50%
Kovack Advisors Inc0.43%
Geode Capital Management, LLC0.41%
UBS Group AG0.39%
Barclays PLC0.03%
Advisor Group Holdings, Inc.0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for 60 Degrees Pharmaceuticals, Inc. Common Stock — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-19.